Is acalatinib included in medical insurance? What is the status of medical insurance reimbursement?

Acalabrutinib is currently on the market in China and is included in the scope of medical insurance reimbursement. As a drug targeting the B cell receptor signaling pathway, acotinib is used to treat a variety of hematological tumors, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). In China, the medical insurance coverage of acotinib provides many patients with a more convenient and economical treatment option.

The drug price of acotinib is relatively expensive, and the price of the original drug is about more than 20,000 yuan per box. Although the price is higher, because it is included in medical insurance, patients can enjoy discounts on medical insurance reimbursement when purchasing. Specific medical insurance reimbursement ratios and conditions may vary from region to region, so it is recommended that patients consult the hospital pharmacy in their region for detailed reimbursement policies and specific costs before purchasing.

Normally, the conditions for medical insurance reimbursement include that the patient meets the treatment indications and the doctor confirms the need to use acotinib. Medical insurance reimbursement rates may vary depending on the patient's medical insurance type and policy. In some areas, the medical insurance reimbursement ratio of acotinib is higher, and the patient's personal burden is lower. But in other areas, patients may still have to pay some out-of-pocket costs. Therefore, patients need to confirm their medical insurance reimbursement status based on specific circumstances.
In addition, although the domestic price of acotinib is higher, there are also cheaper generic versions abroad. For example, the price of the Lao version of acotinib is about more than 3,000 yuan, which is much cheaper than the domestic original drug, and its drug ingredients are basically the same as the original drug. Patients can choose to purchase original drugs or generic drugs according to their own financial situation. When choosing generic drugs, patients should also communicate with their doctors to ensure the efficacy and safety of the drugs.
Reference: https://www.calquence.com/